Intermittent Education and Audit and Feedback Reduce Inappropriate Prescribing of Oral Third-Generation

Insights

Antimicrobial stewardship interventions significantly reduced inappropriate oral third-generation cephalosporin prescribing in pediatric clinics. These improvements were sustained, even with decreased provider participation in stewardship activities.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Stewardship
  • Quality Improvement in Healthcare

Background:

  • High rates of oral third-generation cephalosporin (oTGC) use were identified in a pediatric ambulatory care network.
  • Concerns were raised regarding inappropriate oTGC prescribing practices in outpatient clinics.

Purpose of the Study:

  • To reduce inappropriate oTGC prescribing by 15% within one year at a specific clinic (Clinic A).
  • To evaluate the effectiveness of quality improvement interventions on antibiotic prescribing patterns.

Main Methods:

  • A quality improvement team implemented Plan-Do-Study-Act (PDSA) cycles, including educational sessions and audit/feedback.
  • The primary outcome measured was the percentage of oTGCs not aligning with American Academy of Pediatrics (AAP) guidelines.
  • oTGC prescribing at Clinic A was compared to four control clinics.

Main Results:

  • Inappropriate oTGC prescribing at Clinic A decreased from 72% to 45% post-intervention, a statistically significant reduction.
  • This reduction was sustained for the year following the intervention period.
  • Total oTGC prescribing decreased at Clinic A but not in control clinics, despite declining provider participation.

Conclusions:

  • Intermittent education and audit/feedback effectively reduced oTGC misuse in pediatric outpatient settings.
  • Prescribing improvements were maintained, suggesting that ongoing audit perceptions can sustain stewardship efforts.
  • Quality improvement initiatives are crucial for optimizing antibiotic prescribing in ambulatory care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
108
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
119
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
106
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
375
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
77
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89